LAWRENCE, Kansas, Jan. 20 -- The University of Kansas issued the following news: It's time to celebrate Jayhawk colleagues' achievements: KU News Service staff accepted submissions and combed websites, social media and newsletters for recent external honors and awards for current faculty and staff at the Lawrence, Edwards and Medical Center campuses and affiliates. KU Kudos is published six times a year. Have something to share? Submit by March 1 for the next edition. Self-nominations are enco  more

STILLWATER, Oklahoma, Jan. 20 -- Oklahoma State University issued the following news: The beginning of 2024 brought a shift to Oklahoma State University's College of Arts and Sciences leadership team: Renee Tefertiller retired as CAS director of fiscal operations, and new-to-OSU Ann Nelson was hired in her stead. "As a lifelong learner, I feel at home in an academic environment, and the duties and responsibilities of this role resonated with me," Nelson said. "It's the best of all things I en  more

NORMAN, Oklahoma, Jan. 17 (TNSres) -- The University of Oklahoma issued the following news release: "Precision medicine," an emerging approach to health care in which a patient's genetics, diseased tissue and other factors guide clinicians to personalize treatment strategies, can dramatically improve health outcomes for people with various diseases, notably cancer. Years of analysis of cancer specimens makes such targeted treatment possible, yet the samples being studied in the United States a  more

OKLAHOMA CITY, Oklahoma, Jan. 20 (TNSres) -- The University of Oklahoma Health Sciences Center issued the following news: Results of a global clinical trial published recently in The New England Journal of Medicine show that a new drug significantly improves survival in women with epithelial ovarian cancer, a deadly gynecologic cancer that often becomes resistant to chemotherapy. The lead author of the study is Kathleen Moore, M.D., associate director of clinical research at OU Health Stephenso  more

OKLAHOMA CITY, Oklahoma, Jan. 20 (TNSres) -- The University of Oklahoma issued the following news release: Results of a global clinical trial published recently in The New England Journal of Medicine show that a new drug significantly improves survival in women with epithelial ovarian cancer, a deadly gynecologic cancer that often becomes resistant to chemotherapy. The lead author of the study is Kathleen Moore, M.D., associate director of clinical research at OU Health Stephenson Cancer Center  more